key: cord-1048180-57c0ma2g
authors: Piazza, Thais; Moreira, Daniela Pena; da Rocha, Hugo André; Lana, Agner Pereira; Reis, Ilka Afonso; Santos, Marcos Antônio da Cunha; Guerra-Júnior, Augusto Afonso; Cherchiglia, Mariangela Leal
title: Comorbidities and in-hospital death of viral pneumonia adults admitted to SUS (2002–2015)
date: 2021-07-05
journal: Revista de saude publica
DOI: 10.11606/s1518-8787.2021055003109
sha: ee4f63d7449aba5b2858b596c38357eb87adb69c
doc_id: 1048180
cord_uid: 57c0ma2g

OBJECTIVE: To identify demographic and clinical characteristics of adult patients hospitalized in the Brazilian Unified Health System (SUS) due to viral pneumonia and investigate the association between some comorbidities and death during hospitalization. METHODS: This retrospective cohort study was conducted with secondary data of adults admitted to SUS due to viral pneumonia between 2002 and 2015. Patient profile was characterized based on demographic and clinical variables. The association between the ten Elixhauser comorbidities and in-hospital death was investigated using Poisson regression models with robust standard errors. Results were quantified as incidence rate ratio (IRR) with 95% confidence intervals (CI), and we built five models using successive inclusion of variables blocks. RESULTS: Hospital admissions for viral pneumonias decreased throughout the study period, and it was observed that 5.8% of hospitalized patients had an in-hospital death. We observed significant differences in demographic and clinical characteristics by comparing individuals who died during hospitalization with those who did not, with the occurrence of one or more comorbidities being more expressive among patients who died. Although not considered risk factors for in-hospital death, chronic pulmonary disease and congestive heart failure were the most common comorbidities. Conversely, IRR for in-hospital death increased with other neurological disorders, diabetes, cancer, obesity, and especially with HIV/AIDS. CONCLUSIONS: Individuals presenting with pulmonary and cardiovascular diseases require proper attention during hospitalization, as well as those with other neurological diseases, diabetes, cancer, obesity, and especially HIV/AIDS. Understanding the influence of chronic diseases on viral infections may support the healthcare system in achieving better outcomes.

According to the World Health Organization (WHO), lower respiratory infections ranked as the fourth leading cause of death worldwide in 2016, with more than 7.7 million cases just in the Americas. Brazil ranks fifth among 183 countries for mortality from lower respiratory infections, with an estimate of 92.5 deaths per 100 000 individuals 1 . Part of this group of infections, pneumonias are inflammatory conditions mostly caused by bacterial pathogensalthough a systematic review with meta-analysis of studies conducted in the Europe verified that viral infections are responsible for 22-29% of pneumonias affecting adult patients 2 .

Severe viral infections may lead to viral pneumonias 3 , whose morbidity and mortality in adults depends both on the type of virus causing the disease and on patient characteristics, especially regarding chronic comorbidities [4] [5] [6] . Viral spread at pandemic levels and the corresponding public health interventions to cope with this situation also requires attention 7 . A recent concern in that regard was to comprehend the effects of chronic comorbidities on the coronavirus disease . Although diseases such as hypertension, respiratory diseases, and cardiovascular disease may be risk factors for severe patients when compared with non-severe patients, further studies are required to advance knowledge on this association 8 .

Thoroughly understanding the association between death from viral pneumonias and previous chronic diseases may help improving patient care. Thus, this study aimed to 1) identify demographic and clinical characteristics of adult patients hospitalized in the Brazilian Unified Health System (SUS) due to viral pneumonia and 2) estimate in-hospital death risk according to their comorbidities profile. For that, we investigated the association between some comorbidities and death during hospitalization due to viral pneumonia.

This is a retrospective cohort study conducted with data from 2000 to 2015 extracted from the National Database of Health -an individual-centered dataset that employs record linkage techniques to integrate data from the main Information Systems of the Brazilian Unified Health System (SUS): Ambulatory Information System (SIA), Hospital Information System (SIH), and Mortality Information System (SIM) 9 .

Our study sample comprises patients aged between 19 and 100 years who were hospitalized between January 2002 and May 2015 in SUS due to viral pneumonia. Hospitalization records whose primary or secondary diagnosis at admission included one of the following codes of the International Classification of Diseases (ICD-10) were considered as corresponding to viral pneumonia: J10.0, J11.0, J12.0, J12.1, J12.2, J12.8, or J12.9. For patients hospitalized more than once due viral pneumonia during the study period, only data regarding the last admission were considered.

In-hospital death -that which occurred between the admission and the discharge datewas the dependent variable of this study.

Patient profile was characterized based on the following variables: I) demographic, including gender (female, male), age, race/skin color (white, black, brown, yellow, and indigenous), region of residence (North, Northeastern, Southeastern, South, Midwest), classification of the location of residence according municipality into either "rural" (area predominantly rural remote or rural close to a city) or "urban" or "intermediary" (area intermediary remote or intermediary close to city) 10 ; and II) clinical, including name and number of the Elixhauser comorbidity (none, one, two or more) 11 , number of previous hospitalizations due to viral pneumonia, year of the last hospitalization due to viral pneumonia, diagnosis at admission (according to the ICD-10), mixed bacterial pneumonia on admission (yes, no), admission to Intensive Care Unit (ICU) (yes, no), total length of stay and total ICU length of stay (days).

Based on the hospitalization date, we retrospectively investigated all ICD-10 codes registered at the National Database of Health, extending the lookback period to the oldest record available (01/01/2000). Therefore, all patients had at least two complete years of lookback period to register comorbidities.

We investigated the effect of ten Elixhauser comorbidity groups 11 on in-hospital death during hospitalization for viral pneumonia, namely: chronic pulmonary disease, congestive heart failure, cancer (metastatic cancer and solid tumors without metastasis), hypertension (uncomplicated and complicated), diabetes mellitus (uncomplicated and complicated), renal failure, liver disease, other neurological disorders (neurological disorders not involving paralysis), HIV/AIDS, and obesity.

Categorical variables were expressed as absolute and relative frequency distributions, and quantitative variables were summarized using measures of central tendency (mean and median) and measures of variability (standard deviation and interquartile interval).

The outcome in-hospital death for each patient was registered as a binary variable (yes or no). These two groups (those who died during hospitalization and those who did not) were compared regarding their characteristics using chi-squared tests for categorical variables and Mann-Whitney U test for quantitative variables. A p-value less than 0.05 (p < 0.05) was considered significant. The association between in-hospital death and each of the ten selected Elixhauser comorbidities was separately investigated using Poisson regression models with robust standard errors and quantified as incidence rate ratio (IRR) with 95% confidence intervals (CI) 12 . We built five models using successive inclusion of variables, and all of them included the follow-up time logarithm as an offset term. Model 0 included only the non-adjusted comorbidity. Model 1 included Model 0 variable and was adjusted for demographic variables (considering biological characteristics, and factors related to hospital access). Model 2 was built by adding the hospitalization year (a temporal trend that can be related to hospital structure and available treatments) to Model 1. Model 3 included Model 2 variables added of clinical variables (related to the severity of viral pneumonias). Finally, Model 4 included all variables present in Model 3 and data on other comorbidities presented by the patient.

Model 4 underwent multicollinearity analysis, and no signs of multicollinearity were detected. Data were analyzed using the R statistical programming environment 13 . Robust standard errors were estimated using the sandwich R package, and indicator variables for Elixhauser comorbidities were created using the comorbidity R package.

This study comprises the project "Epidemiological, economics and care paths of high-cost procedures in SUS: use of patient-centered database from the integration of health information system records", approved by the Research Ethics Committee of the Universidade Federal de Minas Gerais, under Protocol number: CAAE 44121315.2.0000.5149.

From 2002 to May 2015, 629,026 adult patients were admitted in the Brazilian Unified Health System (SUS) to treat viral pneumonias. Of these, 5.8% died during the hospitalization. The largest number of hospitalizations for viral pneumonia occurred during the first triennium of the studied period, with around 60 thousand cases each year ( Figure 1 ). After this period, we observed a higher proportion of in-hospital death, increasing from 4.6% to 6.9% on average between 2010 and 2014 ( Figure 1 ).

Most patients hospitalized presenting with this condition were women (51.1%) with median age of 57 years. Yet, those who died were predominantly men (54.1%) and older (median 75 years) ( Table 1) . Data on race/skin color was irregular among studied patients. Northeast, Southeast, and South were the regions with higher hospitalizations and in-hospital deaths, and most patients lived in urban areas. Regarding clinical history (Table 1) , the occurrence Continue of one or more comorbidities was more expressive among patients who died when compared to those who did not. Chronic pulmonary disease and congestive heart failure were the most common comorbidities among patients who died, as well as in the overall study sample. Previous hospitalizations due to viral pneumonias were fairly uncommon, although slightly higher among those who died ( Table 1) .

As for clinical aspects at hospital admission (Table 2) , 66.3% of the cases did not specify the type of virus responsible for the condition, with rare occurrence of mixed bacterial pneumonia. The average length of stay was higher among patients who died, for whom the requirement of ICU admission was more than six times greater when compared to patients who survived.

According the regression analysis (Table 3) , only the comorbidity group relative to liver disease did not behave as a risk factor for in-hospital death on the unadjusted model (Model 0). However, after the due adjustments, renal failure (Models 2 to 4) was not significantly associated with in-hospital death, and chronic pulmonary disease, congestive heart failure, and hypertension were no longer risk factors (Models 1 to 4), although still associated with death. The magnitude of association between most comorbidities and in-hospital death decreased after adding demographic characteristics (Model 1), which presented an inverted association for liver disease, obesity, and especially for HIV/AIDS. Overall, the subsequent aggregation of correction factors (hospitalization year and clinical characteristics) slightly reduced the magnitude of the associations, but we verified a markedly decrease in the association regarding HIV/AIDS, liver disease, and especially obesity (Model 4).

None of the five models showed a significant association between liver disease and in-hospital death, but five comorbidities remained as risk factors for this outcome from Model 0 to Model 4. According to Model 4, other neurological disorders increased the risk of death by around 14%, diabetes by 18%, cancer by 18% (cancer), obesity by 87%, and HIV/AIDS by 126%. 

Hospitalizations for viral pneumonias among adults in the Brazilian Unified Health System (SUS) decreased from 2002 to 2015, but in-hospital death was 5.8% on average during this period. We observed significant differences between the demographic and clinical characteristics of patients who died during hospitalization when compared to those who did not. A total of 68.1% of patients who died had at least one comorbidity, whereas among survivors this value was 45.4%. Also, for each comorbidity group, the mostly affected were those who died too. Besides the adjustment factors, eight of the ten Elixhauser comorbidity groups were associated with death among viral pneumonia patients.

We observed a progressive reduction on hospital admissions due to viral pneumonias up from 2002, following a downward trend for lower respiratory diseases observed worldwide 1 .

For example, a relative stability of influenza-associated hospitalization rate in the Americas was observed after 2011 14 . As shown in Figure 1 , two main reasons may justify this downward trend in the Brazilian context: the high levels of influenza vaccination coverage during this period 15 ; and the expanded targeted immunization strategy, including pregnant women, indigenous people, and health workers up from 2011, and individuals presenting with chronic non-communicable diseases or other special conditions and postpartum women up from 2013 (besides the normal coverage of people aged ≥ 60 years) 16 . We also verified some fluctuations within hospital admissions, which may be explained by the 2003 and 2007 pandemic caused by influenza A (H3N2) virus 7 and the 2009 pandemic of H1N1 15 . Despite the reduction in hospitalization rates for viral pneumonia, in-hospital deaths increased in the first period and stabilized thereafter. Such stabilization corroborated levels previously observed in the United States (7.5% between 2000 and 2002 for patients over 65 years old) 17 and in Japan (7.4% between 2011 and 2014 for patients over 65 years old) 4 .

Influenza vaccination remains a powerful strategy to prevent viral infections. An ecological study conducted in Argentina found no differences in the mortality rates of adults and older adults before and after influenza vaccination between 2002 and 2016 3 . These results indicate the need for establishing public health policies 18 and overcoming barriers regarding influenza vaccination according to the perception of each target population (for example, by providing information on its risks and benefits). In Chile, health authorities implemented specific programs for the primary healthcare of adults with respiratory diseases 19 . These practices may prevent new cases of the disease and support in early treatment.

Regarding demographic characteristics, most patients who died during hospitalization for viral pneumonia were men (54.1%), despite being the minority of our study sample (48.9%). Likewise, a study conducted with data from some Asian countries verified a higher prevalence of male deaths (69.7%) 20 , but these regions presented a higher proportion of men within the total population (61.2% 20 and 60.8% 4 ). A study conducted with a nationally-representative sample of the Brazilian population aged 50 years or older evaluating the factors associated with hospital admission 21 found a lower hospitalization rate among individuals residing in rural areas and in the Midwest and North regions of the country when compared to the overall population, corroborating our results. However, these demographic characteristics also were positively associated with hospitalizations, possibly due to the difficulties in providing effective primary healthcare within these areas 21 .

Similar to our results, other studies verified a higher frequency of hospital admissions due to viral pneumonia among older adults 4, 17 . They also verified a decrease in the hospitalization rate owing to this condition among individuals aged ≥ 85 years, corroborating our results regarding individuals aged ≥ 80 years. Concerning clinical characteristics, over half of the patients admitted to SUS with viral pneumonia presented no history of comorbidities. This proportion is higher than that observed for adults in Shanghai between 2015 and 2019 (31.6%) 20 , and for patients over 65 years in the United States between 2000 and 2002 (12.7%) 17 . Both in our study and in other studies addressing related themes 17, 20, 22, 23 , chronic pulmonary disease, cardiovascular disease, and diabetes featured (in different orders) within the top five comorbidities. The major variations among studies were related to cardiovascular diseases, especially hypertension, which in general occupied either the first or second position, followed by diabetes 20, 22, 23 ; and cancer, which was the third most frequent comorbidity in one of the studies, and only among patients who died 20 . The large proportion of patients without comorbidities and the relative low frequency of hypertension and diabetes among our study sample may be due to underreporting. Cardiovascular disease, diabetes, and hypertension are one of the most frequent diseases affecting hospitalized patients in Brazil 21 . In SUS, patients with chronic non-communicable diseases such as diabetes and hypertension tend to receive care only in the primary healthcare, whose data is not available in the National Database of Health 9 .

We verified a lack in the specification of viral type at hospital admission, which occurs not only in Brazil, but also in several American countries. Such poorness highlights the problem of deficient data on virologic predominance 14 . When compared to patients admitted to SUS, other studies reported a length of stay two 23 or four 20 times greater. As for ICU admission rates, the demand for intensive care was ten times higher among patients who died than among those who did not, but the overall length of stay was the same for both groups. Another study found the demand for intensive care to be 3 times greater among the group with the worst outcome 20 , but other study found no significant difference 23 .

In our results, chronic pulmonary disease and congestive heart failure were not risk factors for in-hospital death among patients admitted with viral pneumonia. At admission, fatigue, shortness of breath, and chest pain can be interpreted as clinical exacerbations of chronic pulmonary disease and/or congestive heart failure rather than viral pneumonia 17 . For properly distinguishing these conditions, the health professional must assess other clinical aspects, such as fever, hemodynamic changes, and greater elevation of biomarkers, as well as radiographic characteristics 24 that may have been identified during the hospitalization.

In this sense, we may rightfully infer the occurrence of underreport of viral pneumonias among patients presenting with these two comorbidities. As a result of these pre-existing conditions, symptoms onset tend to be quick and intense 4, 22, 24 , reducing the time gap until hospitalization and treatment and thus leading to better outcomes. This allow us to assume that the obtained IRR is questionable, and that it expands the results regarding chronic pulmonary disease 4,23,24 , congestive heart failure 22 , and hypertension 20,23 available in the literature.

In our study, neurological disorders, diabetes, cancer, and HIV/AIDS comprised risk factors for deaths in patients admitted with viral pneumonias. Directly or indirectly, a review performed by the WHO on the clinical aspects of the H1N1 pandemic likewise highlighted the role of these factors 5 . We found obesity to be the Elixhauser group with largest variation in confidence interval (IRR 1.87, 95% CI 1.37-2.54), despite being the second comorbidity most associated with in-hospital death. We also verified a smaller number of patients with obesity when compared to other comorbidities, which may be explained by underreporting at hospital admission, just as occurred for diabetes and hypertension. Some studies consider that the immunological effects of "chronic inflammation" may facilitate the occurrence of infectious diseases 6 . However, according to the WHO, morbid obesity was the only risk factor suggested (but not proved) to be independent 5 . Obese patients tend to present with other comorbidities 5 , which may justify the largest -as shown by the marked decrease in IRR on Model 4, after the addition of other comorbidities as adjustment factors. Regardless of the above exposed, we verified a greater correlation between obesity and the analyzed outcome than other neurological disorders, diabetes, and cancer, even in the worst-case scenario.

As with obesity, immunological disorders in patients with diabetes seem to favor viral infections 6 , and patients with diabetes have a twofold chance of developing severe pneumonia 22, 23 . This finding is corroborated by the fact that diabetes remained a risk factor in all of our models, with a slight increase in the association strength before the introduction of other comorbidities as adjustment factors. This may be explained by the association between diabetes and renal failure (which led to a reduction in the association strength in Model 4), as in-hospital death rate is higher among patients with renal disease who present with other comorbidities than among those who do not 25 , despite possibly justifying the lack of association in the group with renal failure.

Although a permanent risk factor in all five models, the negative impact of solid tumors with or without metastasis on viral infections is not yet unanimous in the scientific literature. According to WHO, immunosuppression is a clinical condition caused by HIV/AIDS, transplants, and chemotherapy 5 that comprises a relevant risk factor for viral infections. Cancer-induced immunosuppression addresses but some of the patients with neoplasia, and studies approaching this broader group are still scarce and usually conducted with more patients affected by hematologic malignancies than solid tumors and/or a specific type of virus 26, 27 . However, corroborating our findings, a German study reported a high incidence of pneumonia and high mortality rates for influenza regardless of the underlying malignant disease 27 .

Liver diseases likewise account for a scarce number of studies evaluating its association with mortality by viral pneumonias. Although we verified no association between this comorbidity group and death due to viral pneumonias, a recent study conducted with cirrhotic patients, and thus susceptible to complications 5 , found an increased mortality among those affected by respiratory viruses 28 .

Our results indicate that HIV/AIDS comorbidity group comprises the main risk factor for in-hospital death among patients with viral pneumonia. As aforementioned, HIV-positive patients may present with immunosuppression -the real risk factor for the evaluated outcome 5 . However, both our and another study 29 reinforce that HIV/AIDS comprises a risk factor even when the HIVpositive patient is not affected by the immunodeficiency syndrome. In our study, the addition of adjustment factors to the built models greatly influenced the association between HIV/AIDS and in-hospital death. Sociodemographic characteristics favored the magnitude of association for HIV/AIDS, as observed for liver disease and obesity. Simultaneously, but to a lesser extent, the association intensity decreased by adding other diseases into the final adjusted model (Model 4), which may be explained by the activity of chronic obstructive pulmonary disease and congestive heart failure as independent risk factors for respiratory infections among HIV-positive patients 29 .

With this, IRR increased in the final model whereas the HIV/AIDS group association decreased. Regardless of the exposed, HIV/AIDS remained the comorbidity of greater risk for in-hospital death among adult patients admitted into SUS with viral pneumonia.

Our study has some limitations. First, the searched database contained only administrative data on hospital admission, so that any diagnoses established during hospitalization were underestimated, such as the definition of either viral (patients not included) or bacterial (clinical coinfection impact 30 ) pneumonias. We also did not assess all primary healthcare comorbidities, but we included the entire history of procedures and admissions available for each patient to reduce the impact of such loss. Moreover, data on race/skin color was more completed for the patients who died, so we opted by not including this variable as adjustment factor to avoid a relevant bias. Despite the limitations inherent to our study, the literature contains but a limited amount of studies evaluating the influence of such great number of comorbidities, using a wide population, and throughout a large study period.

More than simply identifying the risk factors of comorbidities for in-hospital death among adults admitted with viral pneumonia, one must also understand the underlying mechanisms of each association, either confirmed or not. Individuals presenting with pulmonary and cardiovascular diseases require proper attention, as well as those with other neurological diseases, diabetes, cancer, obesity, and especially with HIV/AIDS. Moreover, the Brazilian Unified Health System and every healthcare system must be prepared to deal with infectious disease such as the COVID-19. Thus, understanding the influence of chronic diseases on viral infections may support in public health policies decision-making, for example by defining priority groups to receive a new vaccine and improving early diagnosis on pandemic contexts.

Global Health Estimates 2016: disease burden by cause, age, sex, by country and by region

Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe

Mortalidad atribuible a gripe en los períodos prevacunación y posvacunación en Argentina: estudio ecológico (2002-2016)

The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study

Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1)

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

Obesity, diabetes and pneumonia: the menacing interface of non-communicable and infectious diseases

Excess of mortality in adults and elderly and circulation of subtypes of influenza virus in southern Brazil

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Building the National Database of Health centred on the individual: administrative and epidemiological record linkage -Brazil

Classificação e caracterização dos espaços rurais e urbanos do Brasil: uma primeira aproximação -2017

Comorbidity measures for use with administrative data

Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio

R: a language and environment for statistical computing. Vienna (AT): R Foundation for Statistical Computing

Burden of influenza-associated respiratory hospitalizations in the Americas

Efetividade da estratégia brasileira de vacinação contra influenza: uma revisão sistemática

Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. Programa Nacional de Imunizações (PNI): 40 anos

Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States

Influenza vaccine uptake among older adults in Brazil: socioeconomic equality and the role of preventive policies and public services

Impacto de los programas de salud ERA y GES en la mortalidad por neumonía adquirida en la comunidad en personas de 65 años o más en Chile

Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score

Hospitalizations among older adults: results from ELSI-Brazil

Etiology and factors contributing to the severity and mortality of community-acquired pneumonia

Deaths in admissions due to viral pneumonia

Influenza A-associated severe pneumonia in hospitalized patients: risk factors and NAI treatments

Differences between acute exacerbation of COPD and pneumonia in patients with COPD

Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey

Burden of human metapneumovirus infections in patients with cancer: risk factors and outcomes

Influenza virus infections in patients with malignancies -characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO)

Spectrum of respiratory viral infections in liver disease patients with cirrhosis admitted in critical care unit

Association of COPD with risk for pulmonary infections requiring hospitalization in HIV-infected veterans

Viral infection in communityacquired pneumonia: a systematic review and meta-analysis